NCT07102394 2026-02-17
Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1
Johns Hopkins University
Phase 1 Recruiting
Johns Hopkins University
Shengjing Hospital
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Medical College of Wisconsin
Centre Leon Berard